pyrindamycin a has been researched along with B16 Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hartley, JA; Hudson, S; Kiakos, K; Lee, M; Lingerfelt, B; Purnell, B; Scott, A; Summerville, K; Townes, H | 1 |
1 other study(ies) available for pyrindamycin a and B16 Melanoma
Article | Year |
---|---|
Novel (S)-(-)- and R-(+)-seco-iso-cyclopropylfurano[e]indoline-5,6,7-trimethoxyindole-2-carboxamide (iso-CFI) analogs of duocarmycin C2: synthesis and biological evaluation.
Topics: Animals; Antineoplastic Agents, Alkylating; Base Sequence; Cell Proliferation; DNA; Drug Screening Assays, Antitumor; Duocarmycins; Heterocyclic Compounds, 3-Ring; Indoles; Leukemia L1210; Melanoma, Experimental; Mice; Models, Chemical; Pyrroles; Stereoisomerism; Tumor Cells, Cultured | 2006 |